• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Number of OE-recommended and posted health fraud internet site warning letters

Dictionary: The Office of Enforcement’s (OE) Health Fraud team is responsible for identifying firms engaging in internet health fraud and recommending Warning Letters. Warning Letter recommendations are sent to the Center for approval and then posted on FDA.gov. OE's Health Fraud team has been responsible for initiating approximately 15% of all Warning letters issued by FDA each year. We will measure the volume and success of OE’s health fraud surveillance work by the number of recommended warning letters and the resulting enforcement action.

Information is current as of February 12, 2013.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetNumber of recommended WLs
Oct 2011N/A5
Nov 2011N/A4
Dec 2011N/A0
Jan 2012N/A2
Feb 2012N/A1
Mar 2012N/A3
Apr 2012N/A3
May 2012N/A1
Jun 2012N/A2
Jul 2012N/A1
Aug 2012N/A2
Sep 2012N/A0

FY 2012 Total: 24

Percent of OE-recommended health fraud internet site warning letters approved by the Center for issuance and posting on FDA.gov

Dictionary: The Office of Enforcement’s (OE) Health Fraud team is responsible for identifying firms engaging in internet health fraud and recommending Warning Letters. Warning Letter recommendations are sent to the Center for approval and then posted on FDA.gov. OE's Health Fraud team has been responsible for initiating approximately 15% of all Warning letters issued by FDA each year. We will measure the volume and success of OE’s health fraud surveillance work by the number of recommended warning letters and the resulting enforcement action.

Fiscal Year - 2012

Skip graphic and jump to text data

TimeTargetPercent
Oct 2011100100
Nov 2011100100
Dec 2011100100
Jan 2012100100
Feb 2012100100
Mar 2012100100
Apr 2012100100
May 2012100100
Jun 2012100100
Jul 2012100100
Aug 2012100100
Sep 2012100100

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.